A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection. (2022)

First Author: Lage DP
Attributed to:  VAccine deveLopment for complex Intracellular neglecteD pAThogEns (VALIDATE) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/vaccines10071146

PubMed Identifier: 35891310

Publication URI: http://europepmc.org/abstract/MED/35891310

Type: Journal Article/Review

Volume: 10

Parent Publication: Vaccines

Issue: 7

ISSN: 2076-393X